BioXcel Therapeutics
BTAI
#9513
Rank
A$40.53 M
Marketcap
$0.99
Share price
2.37%
Change (1 day)
-86.48%
Change (1 year)

Market capitalization of BioXcel Therapeutics (BTAI)

Market cap: A$40.53 Million

As of November 2024 BioXcel Therapeutics has a market cap of A$40.53 Million. This makes BioXcel Therapeutics the world's 9513th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioXcel Therapeutics from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024A$40.53 M-68.02%
2023A$0.12 B-85.67%
2022A$0.88 B12.74%
2021A$0.78 B-46.52%
2020A$1.46 B288.69%
2019A$0.37 B339.78%
2018A$85.82 M

End of Day market cap according to different sources

On Nov 4th, 2024 the market cap of BioXcel Therapeutics was reported to be:

A$39.59 Million
by Yahoo Finance info icon info icon
A$39.59 Million
by CompaniesMarketCap info icon info icon
A$39.59 Million
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.96 B 2,286.47%๐Ÿ‡บ๐Ÿ‡ธ USA